Our Returns in the Third Quarter of 2023
How a good defence was our best offence
The third quarter (Q3) of 2023 started off strong, with equity markets continuing a tech-fueled rally into July. But the markets lost momentum in August and September, as strong US economic data and sticky inflation led to a more hawkish tone from the US Federal Reserve.
Given expectations that interest rates would remain ”higher for longer”, longer-term US yields rose, which pulled down bond prices (recall that bond yields and prices are inversely related). Stocks also gave up some of their year-to-date (YTD) gains due to those higher yields, with the technology sector being more sensitive to longer-term interest rates.
Ultimately, both the equity and bond markets ended the quarter lower than where they started, with global equities now up about 10% for the year to end-September, and bonds down 3%.
In our mid-year market outlook, we highlighted the importance of maintaining a more defensive positioning amid uncertainty over growth and inflation dynamics, which appears to be playing out now. This meant an overweight on short-dated US Treasury bills, given the attractive yield on cash-like assets.
Our defensive positioning helped us to largely outperform our benchmarks, both in Q3 and for the year to end-September. This positioning remains unchanged as our investment framework, ERAA™, continues to place us in a stagflationary regime.
With that in mind, let’s look at how our portfolios performed in Q3:
- General Investing and Goal-based Investing
- Thematic Portfolio
General Investing portfolios
Outperforming our benchmarks
StashAway’s General Investing (GI) and Goal-based Investing portfolios declined across StashAway Risk Indexes (SRIs) during Q3. But due to a more defensive positioning, these declines were less pronounced than their same-risk benchmarks across the board. They were down -1.7% on average in USD terms. Compared with an average -3.8% decline for their same-risk benchmarks, outperforming by +2.1 percentage points (ppt).
Taking a longer-term perspective, our portfolios remain in positive territory YTD, and have also largely outperformed their same-risk benchmarks. For the year to end-September they were up +4.4% on average versus average gains of +3.6% for their same-risk benchmarks, resulting in average outperformance of +0.8 ppt.
The rally in equities lost steam in Q3, but returns remain positive YTD
The past few months saw a pullback in equities as higher interest rates weighed on tech and other interest-rate sensitive sectors, like real estate and utilities. This weighed on our higher-risk SRIs, which have a higher exposure to broad-based equity indexes and technology stocks.
For the year to end-September however, our allocations to tech stocks and broad-based equity indexes were still the main drivers behind our portfolios’ positive performance – given how much they rallied in H1. This was especially the case in our higher-risk SRIs.
Pulling in the other direction, US energy stocks were also the main contributors among the equity allocations for our portfolios, with the sharp rise in oil prices over the summer contributing to the sector.
Short-dated bonds remained a cushion, while longer-dated bonds were hit in Q3
On the fixed income side, ERAA™’s allocations to short-dated US Treasury bills (T-bills) have remained the main contributor to our portfolios’ returns for both Q3 and YTD.
This is due to their still-high yields – with T-bills returning about 5.4% per annum as of end-September. Inflation-linked bonds have also been a source of support given the inflationary environment over the past year.
Over the course of Q3 however, longer-dated US Treasury bonds took a hit amid more hawkish rhetoric from central banks, and the potential for interest rates to rise further and stay there for longer. As a result, our allocation to longer-duration US Treasuries were a detractor to our portfolios during the period. That said, we are underweight in longer-dated bonds compared to our benchmarks, which contributed to our relative outperformance.
Gold posted losses in Q3, but hasn’t lost its lustre as a defensive asset
Our allocations to gold were also a detractor in Q3 as increasing bond yields, a strong US dollar, and the “higher for longer” narrative mentioned above weighed on prices of the precious metal. During the quarter, gold posted returns of -3.8% in USD terms.
But over a longer time horizon, gold can still play the role of a defensive asset in diversified portfolios. Amid this year’s volatile market, gold posted returns of +1.1% YTD in USD terms. Looking ahead: the potential for an eventual recession in the US and other economies, as well as the impact of recent geopolitical turmoil in the Middle East, point to sources of support for gold.
Our defensive allocations continued to shield our portfolios from volatility and drawdowns
The relatively defensive nature of our portfolios continued to protect our portfolios during the renewed bouts of market volatility during the past few months – especially so in our lower-risk SRIs. On average, our asset allocations had annualised volatility (in USD terms) of 5.6% versus 7.7% for our benchmarks for the year to end-September.
Our portfolios’ lower volatility has resulted in shallower drawdowns, which helps relative performance over a longer period of time – as shown by the widening outperformance of our portfolios versus their benchmarks in the chart below. It also results in higher risk-adjusted returns, which accounts for the amount of risk you take on to achieve returns.
Our portfolios have had a higher average Sharpe ratio of 1.0 for the year to September, compared with 0.4 for their same-risk benchmarks.
The recent pullback in equity and bond markets also weighed on our Thematic portfolios in Q3. Our Technology Enablers and Future of Consumer Tech portfolios, which saw large gains this year on the back of investor enthusiasm in the tech sector, are still up for the year to end-September. But the market environment pulled returns for our Healthcare Innovation and Environment and Cleantech portfolios into negative territory YTD.
It’s important to remember that our thematic portfolios are designed for investors to take a longer-term view on their respective themes, with more defensive, balancing assets to help reduce volatility along the way. Periods of market volatility, like we have today, could present a window of opportunity to enter or add exposure to these trends.
Our Technology Enablers portfolio posted losses of -2.7% on average in USD terms during Q3. However, for the year to end-September, they were still up +16.3% on average.
Aside from the cloud computing sector, most thematic assets in this portfolio posted negative returns in Q3 – though the rally from earlier this year meant that returns remained in the double-digits across the board YTD.
Among our balancing assets, allocations to short-duration US T-bills have remained a source of support in Q3 and YTD. Allocations to longer-duration bonds and gold however, were detractors over the past quarter.
Future of Consumer Tech
Our Future of Consumer Tech portfolios also posted losses in Q3, of -4.6% on average in USD terms. But similar to our Technology Enablers portfolio, their YTD gains remain strong, +12.0% on average.
The thematic sectors in this portfolio posted declines across the board in Q3, for the reasons described above, but largely remained in the double-digits YTD. Similar to our Technology Enablers portfolio, short-dated US Treasuries were the main contributors this year, while longer-dated bonds and gold detracted in Q3.
Our Healthcare Innovation portfolios posted losses of -7.4% on average in USD terms in Q3. That brought YTD returns into negative territory, or -4.0% on average. The largest drags on performance during both Q3 and YTD came from the genomics and healthtech sub-sectors. Modest positive performance in pharmaceuticals pulled in the other direction, as did our allocations to short-duration US T-bills.
Environment and Cleantech
Our Environment and Cleantech portfolios posted losses of -11.2% on average in USD terms in Q3. As with our Healthcare Innovation portfolios, that resulted in negative YTD returns, or -5.1% on average.
Thematic and balancing assets in the portfolio were down across the board as result of the market downturn in Q3. But strong performance from the energy infrastructure, environmental services, and water sectors helped to mitigate losses in our lower-risk SRIs YTD.
Our same-risk benchmarks are proxied by MSCI All Country World Equity Index TRI for equities (prior to 1 March 2023 are proxied by MSCI World Equity Index TRI) and FTSE World Government Bond TRI for bonds. The benchmarks we use have the same 10-years realised volatility as our portfolios.
Model portfolio returns are expressed in gross terms before fees, withholding taxes, and reclaims on dividends. They are provided only as a gauge of pure performance before other items.
Actual account returns may deviate from the model portfolios due to differences in the timing of trade execution (e.g. during the day vs close), timing differences and intraday volatility of reoptimisation and re-balancing, fees, dividend taxes and reclaims, etc. All returns are in USD terms.
Past performance is not a guarantee for future returns. Please study the product's features, return conditions, and relevant risks before making an investment decision.
This communication is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to purchase any financial product or subscribe or enter any transaction.
This communication does not take into account your personal circumstances, e.g. investment objectives, financial situation or particular needs, and shall not constitute financial advice. You should consult your own independent financial, accounting, tax, legal or other competent professional advisors.
We thought you might.
Join the hundreds of thousands of people who are taking control of their personal finances and investments with tips and market insights delivered straight to their inboxes.